IPO Price History
Closed
GP

Gland Pharma Limited IPO

Mainboard IPOListedGLANDNSE
Current Market Price (CMP)
₹2,826.80(+88.45%)
Current Price (CMP)
₹2,826.80(+88.45%)

Live Market Quote

Listing Price & Gain
₹1,710(+14.00%)

Day 1 Exchange Open

IPO Issue Price
₹1,500

Band: ₹1490 - ₹1500

Total Subscription
2.06x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
09 Nov 2020
IPO Bidding Closes
11 Nov 2020
Allotment & Refunds
Completed
Exchange Listing Day
20 Nov 2020

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 2.06x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)6.4x
Non-Institutional Investors (NII / HNI)0.51x
Retail Individual Investors (RII)0.24x
Total Subscription2.06x
Updated as on 11th November 2020 at 1800 hrs

Listing Day & Return Performance

Listing Day Gain+14.00%
₹1,500 (Issue) → ₹1,710 (List)
Per share profit: +₹210.00
Holding Return (Till Date)+88.45%
₹1,500 (Issue) → ₹2,826.80 (CMP)
Net gain per share: +₹1326.80
Post-Listing Performance (Listing Day → Today):+65.31%

About Gland Pharma Limited IPO

Gland Pharma Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 09 Nov 2020 and concluded on 11 Nov 2020, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹1490 - ₹1500.

During the bidding window, Gland Pharma Limited recorded an overall subscription of 2.06 times. Institutional investors (QIB) subscribed 6.4x, non-institutional high-net-worth investors (NII) subscribed 0.51x, and retail individual investors (RII) bid 0.24x their reserved quota.

The equity shares of Gland Pharma Limited officially debuted on the stock exchanges on 20 Nov 2020 at an opening listing price of ₹1,710, delivering a listing day return of +14.00% (premium) over the final issue price. As per the latest market data, the stock trades at ₹2,826.80, representing an overall gain of +88.45% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Gland Pharma Limited IPO?
The issue price of Gland Pharma Limited IPO was fixed at ₹1,500 per equity share. The indicative bidding price band was ₹1490 - ₹1500.
What were the open, close, and listing dates for Gland Pharma Limited IPO?
Gland Pharma Limited IPO opened on 09 Nov 2020, closed on 11 Nov 2020, listed on 20 Nov 2020.
How much was Gland Pharma Limited IPO subscribed?
The IPO received an overall subscription of 2.06 times. Category-wise, QIBs subscribed 6.4x, NIIs subscribed 0.51x, and Retail investors subscribed 0.24x.
What was the listing price and listing gain of Gland Pharma Limited IPO?
Gland Pharma Limited IPO listed on the stock exchange at ₹1,710, delivering a listing gain of 14.00% compared to the IPO issue price of ₹1,500.
Is Gland Pharma Limited IPO a Mainboard or SME IPO?
Gland Pharma Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Gland Pharma Limited IPO since its IPO?
At the latest market quote of ₹2,826.80, Gland Pharma Limited IPO has generated an all-time return of +88.45% since its initial public offering.

Related Mainboard IPOs (2020)

BECTORFOOD
Mrs. Bectors Food Specialities Limited
₹288-65.28%
BURGERKING
Burger King India Limited
₹60Unlisted
EQUITASBNK
Equitas Small Finance Bank Limited
₹33-5.76%
LIKHITHA
Likhitha Infrastructure Limited
₹120+8.33%